A detailed history of Swedbank Ab transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Swedbank Ab holds 149,363 shares of REGN stock, worth $105 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
149,363
Previous 135,658 10.1%
Holding current value
$105 Million
Previous $143 Million 10.12%
% of portfolio
0.2%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$1024.09 - $1201.76 $14 Million - $16.5 Million
13,705 Added 10.1%
149,363 $157 Million
Q2 2024

Jul 18, 2024

BUY
$883.2 - $1071.19 $120 Million - $145 Million
135,658 New
135,658 $143 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $121 Million - $133 Million
134,294 New
134,294 $129 Million
Q4 2023

Dec 09, 2024

BUY
$775.18 - $881.7 $44.4 Million - $50.5 Million
57,238 Added 122.55%
103,943 $91.3 Million
Q3 2023

Dec 09, 2024

BUY
$692.45 - $844.37 $1.88 Million - $2.29 Million
2,715 Added 6.17%
46,705 $38.4 Million
Q2 2023

Dec 09, 2024

BUY
$700.03 - $830.35 $858,936 - $1.02 Million
1,227 Added 2.87%
43,990 $31.6 Million
Q1 2023

Dec 09, 2024

BUY
$680.49 - $826.97 $1.34 Million - $1.63 Million
1,976 Added 4.84%
42,763 $35.1 Million
Q4 2022

Dec 09, 2024

BUY
$705.89 - $766.39 $1.8 Million - $1.96 Million
2,555 Added 6.68%
40,787 $29.4 Million
Q3 2022

Dec 09, 2024

BUY
$573.97 - $724.32 $1.15 Million - $1.45 Million
2,002 Added 5.53%
38,232 $26.3 Million
Q2 2022

Dec 09, 2024

BUY
$548.35 - $738.84 $702,436 - $946,454
1,281 Added 3.67%
36,230 $21.4 Million
Q1 2022

Dec 09, 2024

BUY
$595.12 - $698.43 $236,262 - $277,276
397 Added 1.15%
34,949 $24.4 Million
Q4 2021

Dec 09, 2024

SELL
$543.48 - $670.97 $3.28 Million - $4.05 Million
-6,030 Reduced 14.86%
34,552 $21.8 Million
Q3 2021

Dec 09, 2024

BUY
$574.03 - $680.96 $99,881 - $118,487
174 Added 0.43%
40,582 $24.6 Million
Q1 2021

Dec 09, 2024

BUY
$446.73 - $548.2 $18.1 Million - $22.2 Million
40,408 New
40,408 $19.1 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.